Daicel PESTLE Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
PESTEL Snapshot: How Outside Factors Shape Daicel
Our PESTEL analysis of Daicel explains how political, economic, social, technological, environmental, and legal forces - from regulation and supply – chain shifts to innovations in materials and processes - influence its position across automotive, electronics, healthcare, and packaging. These practical insights help students, investors, and managers see key risks and opportunities; buy the full report for the complete breakdown and ready-to-use charts.
Political factors
Geopolitical Trade Relations
The US-China trade tensions and export controls on advanced materials directly affect Daicel's supply chain and market access; US tariffs and technology restrictions since 2018 have pressured Japanese chemical exporters, with China accounting for ~20% of global chemical demand in 2024.
As a Japanese firm supplying semiconductors and auto components, Daicel faces tariff/exclusion risks that impact ~30% of its sales tied to electronics and mobility markets.
Maintaining diversified manufacturing hubs-Japan, China, Thailand, and the US-reduces regional political risk; capacity shifts in 2023-24 showed a 10-15% reallocation toward Southeast Asia.
Alignment with trade agreements (CPTPP, Japan-EU EPA) and compliance with export controls remains critical to ensure uninterrupted flow of high-performance materials across key markets.
Government Industrial Policy
The Japanese government's economic security push increased funding for domestic critical materials, benefitting Daicel which received JPY 4.2 billion in subsidies and tax incentives for 2023-2024 to advance green chemistry and manufacturing automation.
Policies aim to cut reliance on foreign suppliers-Japan targets 30% domestic sourcing for key electronic and healthcare materials by 2030-prompting Daicel to realign R&D toward prioritized polymers and separation technologies.
Daicel leverages public-private partnerships, contributing to R&D projects totaling JPY 12.7 billion nationwide, aligning its roadmap with national strategic priorities to access grants and preferential tax treatment.
Environmental Regulatory Pressure
Political drives for 2050 carbon neutrality have led Japan, EU and major markets to tighten industrial emission rules and plastics regulations; Japan's 2030 target cuts CO2 by 46% vs 2013 and the EU's Fit for 55 raises carbon pricing exposure, while mandates for bio-based content rise-Daicel faces pressure to shift feedstocks as carbon pricing and bio-mandates could add material costs or limit market access, risking higher levies or lost contracts if adaptation lags.
Global Safety Standards
As a leading pyrotechnic supplier for automotive safety, Daicel faces strict political oversight: global regulations on airbag inflators and emergency systems-spurred by 2023-2025 recalls affecting >10 million vehicles-can force rapid demand shifts or costly redesigns.
Daicel engages proactively with regulators (EU, NHTSA, MAIDS) to anticipate mandates, keeping its products compliant with evolving safety benchmarks and protecting ~$2.7bn FY2024 safety-segments revenue.
- Regulatory risk: recalls >10M vehicles (2023-25) can spike redesign costs
- Proactive engagement: ongoing dialogue with EU, NHTSA, MAIDS
- Financial exposure: safety segment ~¥400bn (~$2.7bn) in FY2024
Supply Chain Sovereignty
Political emphasis on resilient supply chains for semiconductors and EV batteries has raised demand for Daicel's high-grade cellulose and engineering plastics; government subsidies and procurement policies boosted related domestic sourcing by 18% globally in 2024, benefiting specialty-material suppliers like Daicel.
Increasing intervention-tariffs, local content rules, and grant programs in the US, EU and Japan-encourages Daicel to expand localized plants; Daicel reported capital expenditures of ¥46.2 billion in FY2024, with North America/Europe projects accelerated.
Localized production helps Daicel circumvent protectionist barriers and meet local content thresholds (often 30-60% in EV battery supply chains), enhancing contract eligibility with OEMs and government-backed programs.
- 2024 global domestic sourcing up 18%
- Daicel FY2024 CapEx ¥46.2 billion
- Local content requirements typically 30-60%
Daicel faces China risk as Japan subsidies, R&D and JPY46bn CapEx fuel reshoring
US-China trade controls, tariffs, and tech export rules threaten Daicel's supply chains and ~30% sales exposure to electronics/mobility; China ~20% of 2024 chemical demand. Japan's security subsidies (JPY 4.2bn) and JPY12.7bn R&D ties support reshoring; FY2024 CapEx JPY46.2bn; safety segment revenue ~¥400bn (~$2.7bn). Local content requirements 30-60% raise localization needs.
| Metric | Value (2024) |
|---|---|
| China chemical demand | ~20% |
| Sales exposure (electronics/mobility) | ~30% |
| Govt subsidies | JPY 4.2bn |
| R&D partnerships | JPY 12.7bn |
| CapEx | JPY 46.2bn |
| Safety segment rev | ~¥400bn ($2.7bn) |
| Local content reqs | 30-60% |
What is included in the product
Detailed Word Document
Explores how external macro-environmental factors uniquely affect Daicel across six dimensions-Political, Economic, Social, Technological, Environmental, and Legal-backed by current data and trends to identify threats and opportunities for executives, consultants, and entrepreneurs.
Customizable Excel Spreadsheet
A concise, shareable Daicel PESTLE summary that's visually segmented by category for quick interpretation, easily dropped into presentations or planning sessions to align teams and support external risk discussions.
Economic factors
Currency Exchange Volatility
Fluctuations in the JPY/USD and JPY/EUR materially affect Daicel, as exports accounted for about 60% of revenue in FY2024; a weaker yen boosts export competitiveness but raised imported raw material and energy costs by an estimated 4-6% in 2024. Daicel uses forward contracts and FX options, reporting hedges covering roughly 50-70% of near-term exposures, and shifts production locally-raising overseas output to 35% of total capacity by 2025-to dampen currency impacts. Ongoing monitoring of BOJ and Fed policy is critical, with BoJ yield curve adjustments and Fed rate moves in 2024-25 directly driving FX volatility and margin pressure.
Global Inflationary Trends
Persistent inflationary pressures on energy, logistics, and raw materials through late 2025 have pressured Daicel's margins, with global chemical feedstock costs up about 18% year-on-year and Japanese industrial electricity tariffs rising ~12% in 2024-25.
Rising feedstock costs force frequent price adjustments, complicating long-term contracts with automotive and electronics clients that account for over 60% of Daicel's revenue.
Daicel emphasizes operational efficiency via the Daicel Production System to cut waste and energy use; manufacturing cost reductions of 4-6% were targeted in 2024-25 initiatives.
Executives aim to balance cost-push inflation with value-based pricing to protect EBITDA margins, which were around 10-11% in FY2024.
Automotive Market Cycles
Daicel's economic health is tightly linked to automotive cycles: airbags and engineering plastics accounted for roughly 45% of consolidated sales in FY2024, so global vehicle production declines (global auto output fell 3.5% in 2023) can sharply reduce high – margin order volumes.
The EV transition shifts demand toward battery materials and new safety systems, prompting Daicel to invest (capex ~¥40bn in 2024-25) to capture growing EV component markets.
By diversifying into cellulose acetate, polymers and chemical intermediates, Daicel reduced automotive revenue dependence to under 50% by 2024, buffering cyclicality and smoothing cash flows.
Interest Rate Environments
Changes in global interest rates directly affect Daicel's weighted average cost of capital; a 100 bps rise in global rates could raise borrowing costs materially for its JPY-denominated and USD cross-border financing used in plant projects and R&D.
Higher rates increase debt-servicing burdens-Japan's 10-year yield rose toward 0.7% in 2025 from near zero-making large capex more expensive and heightening the need for a strong credit profile to secure favorable terms.
Daicel must prioritize disciplined capital allocation and target project IRRs above its rising cost of capital; maintaining investment-grade metrics supports cheaper long-term funding for chemical plants and innovation.
- Rising global rates → higher WACC and financing costs
- Debt service pressure increases with large-scale capex
- Strong credit profile needed for favorable terms
- Capex/R&D must deliver IRRs exceeding cost of capital
Emerging Market Growth
Economic expansion in Southeast Asia and India - GDP growth ~4.5-6.5% in 2024-25 (IMF regional estimates) - boosts demand for Daicel's plastics and organic chemicals in construction, packaging and consumer electronics as industrialization raises materials intensity.
Stronger commercial and manufacturing presence in these markets captures rising middle – class consumption (household consumption growth ~5-7% in India/ASEAN) and diversifies revenue versus stagnating Japan/Europe.
- SEA/India GDP growth ~4.5-6.5% (2024-25)
- Household consumption growth ~5-7% in high – growth markets
- Higher materials demand in construction, packaging, electronics
- Geographic diversification offsets mature – market headwinds
JPY drag, rising costs shave FY24 EBITDA ~10-11%; capex ¥40bn, overseas 35% by 2025
JPY weakness raised import costs ~4-6% in 2024 despite 60% export share; hedges cover ~50-70% and overseas capacity hit 35% by 2025. Feedstock up ~18% YoY; electricity tariffs +12% (2024-25), squeezing FY2024 EBITDA ~10-11%. Capex ~¥40bn (2024-25); SEA/India GDP ~4.5-6.5% (2024-25). A 100bp rate rise raises WACC and debt service pressures.
| Metric | Value |
|---|---|
| Export share | ~60% |
| Hedge cover | 50-70% |
| Feedstock change | +18% YoY |
| Electricity tariffs | +12% |
| EBITDA FY2024 | 10-11% |
| Capex 2024-25 | ¥40bn |
| SEA/India GDP | 4.5-6.5% |
Full Version Awaits
Daicel PESTLE Analysis
The preview shown here is the exact Daicel PESTLE document you'll receive after purchase-fully formatted, professionally structured, and ready to use for strategic analysis.
Sociological factors
Aging Workforce Demographics
The shrinking, aging Japanese population-median age 48.6 and working-age cohort down ~1.5m since 2015-threatens Daicel's domestic manufacturing capacity, pushing reliance on automation; capital expenditure on factories rose 12% in FY2024 as automation investments scaled. A skills shortage and retirements of senior engineers compel Daicel to fund digital transformation and training academies to retain institutional knowledge. The company targets higher female and foreign-worker participation, aligning with national policies that raised female labor-force participation to 72% in 2024 and eased visa pathways for skilled workers.
Sustainable Consumption Shifts
Growing public concern over plastic pollution and climate change is shifting preferences to eco-friendly products; 72% of global consumers in 2024 say they buy more sustainable goods, driving demand in packaging and textiles.
Demand for biodegradable materials and low-carbon options is rising, with bio-based packaging projected to grow at a 7.1% CAGR through 2028, prompting Daicel to scale cellulose-based alternatives.
Daicel's cellulose solutions target reduced lifecycle emissions and biodegradability, aligning product development with investor and consumer ESG expectations to protect market share and trust.
Health and Wellness Focus
Global health and wellness trends are boosting demand for Daicel's specialized ingredients in pharmaceuticals and cosmetics, with global nutraceutical market projected to reach USD 516.6 billion by 2027, supporting higher sales potential for life sciences inputs.
Consumers prioritize high-quality, safe, effective personal care and healthcare components, increasing willingness-to-pay and favoring Daicel's certified cellulose derivatives and excipients used in drug formulations.
This sociological shift enables expansion of Daicel's life sciences division and R&D into innovative delivery systems for supplements and medicines, aligning with rising global healthcare R&D spending (over USD 260 billion annually in 2024 in select markets).
Research into high-performance cellulose for medical applications directly responds to lifestyle-driven demand, positioning Daicel to capture share in growing medical biomaterials and controlled-release markets estimated to grow mid-single digits annually.
Work-Life Balance and Culture
Changing societal expectations on work-life balance and corporate culture are pushing Daicel to offer flexible work arrangements, mental health programs, and inclusive policies to attract talent; Japan-wide 2024 surveys show 74% of workers value flexibility, influencing hiring competitiveness.
Adopting these practices is essential for Daicel to remain an employer of choice in a tight global market-global talent shortages hit 40% of manufacturers in 2024-while CSR initiatives support retention and external reputation.
- 74% of Japanese workers (2024) prioritize flexibility
- 40% of manufacturers reported talent shortages (2024)
- CSR investments improve retention and brand perception
Safety and Security Expectations
Society's rising intolerance for preventable accidents-global road deaths ~1.3M/year (WHO 2023) and vehicle safety recall rates up 18% in 2024-drives demand for advanced safety features, boosting Daicel's pyrotechnic airbag and seatbelt pretensioner business as automakers add redundant systems.
Public pressure now extends to e-scooters, e-bikes and industrial machinery, with personal mobility injuries rising 12% in 2023; Daicel's controlled-combustion expertise positions it to supply reliable, certified actuation devices for broader safety markets.
Daicel's safety-focused sales: pyrotechnic segment contributed ~28% of 2024 revenue (¥122bn total revenue 2024), reflecting market preference for proven, fast-acting protective technologies.
- Global road deaths ~1.3M/year (WHO 2023); recalls +18% in 2024
- Personal mobility injuries +12% in 2023
- Daicel pyrotechnic ~28% of 2024 revenue
Aging workforce drives automation, sustainable packaging & nutraceutical boom
Shrinking/aging workforce (median age 48.6; working-age -1.5M since 2015) forces automation CAPEX (+12% FY2024); skills gaps push training and foreign/female hiring (female LFPR 72% 2024). Consumer shift to sustainable goods (72% prefer sustainable 2024) raises demand for cellulose bio-packaging (7.1% CAGR to 2028) and boosts life-sciences inputs (nutraceuticals to USD 516.6B by 2027).
| Metric | Value |
|---|---|
| Median age Japan | 48.6 |
| Working-age change | -1.5M since 2015 |
| Automation CAPEX | +12% FY2024 |
| Female LFPR | 72% (2024) |
| Consumers favoring sustainability | 72% (2024) |
| Bio-packaging CAGR | 7.1% to 2028 |
| Nutraceutical market | USD 516.6B by 2027 |
Technological factors
Digital Transformation in Manufacturing
Daicel's AI- and IoT-driven Production System boosts manufacturing efficiency; pilot sites reported a 12-18% increase in yield and 20% lower unplanned downtime in 2024, per company disclosures.
Real-time monitoring and predictive maintenance enabled a 15% reduction in energy intensity (kWh per tonne) across key plants in FY2024, enhancing cost control in a high-cost manufacturing environment.
Digitization improved synthesis precision, cutting batch variance by ~10% and reducing off-spec production, supporting margin resilience amid rising input costs.
Advancements in 6G and AI Materials
As 6G and AI compute drive a projected $1.2 trillion telecom+datacenter upgrade by 2030, demand for low-dielectric materials is rising; Daicel's high-performance resins and films target <0.02 loss tangent and thermal conductivity improvements of ~15%, enabling faster signal speeds and better heat dissipation in devices.
Bio-Refinery and Circular Tech
Daicel is scaling bio-refinery R&D to convert non-edible biomass into cellulose acetate and derivatives, targeting a >30% reduction in fossil feedstock use by 2030; pilot yields report enzymatic conversion efficiencies rising from ~45% (2021) to ~62% (2024). These enzymatic and advanced chemical processes cut CO2 intensity per ton of product by an estimated 25-35%, support circular feedstock loops, and align with capex allocated to sustainability-≈¥40-60bn guidance through 2025-2026.
Next-Generation Battery Materials
The shift toward solid-state and high-energy lithium chemistries demands new binders, separators and additives; Daicel leverages organic-chemistry expertise to target higher energy density and safety for EV cells, addressing a market growing at ~20% CAGR to 2030.
Strategic partnerships with OEMs and battery makers are central for co-development-Daicel reported ~¥300bn group sales in FY2024, enabling R&D scale to stay at the chemistry frontier as transport electrification accelerates.
- Focus: binders, separators, additives for solid-state/high-energy cells
- Market context: EV battery market ~20% CAGR to 2030
- Capability: organic-chemistry R&D, FY2024 group sales ~¥300bn
- Strategy: co-development with OEMs and battery manufacturers
Micro-Gas Generator Innovation
Daicel is adapting pyrotechnic expertise to healthcare via micro-gas generators for needle-free drug delivery, leveraging precision combustion beyond airbags to penetrate skin painlessly and boost patient adherence.
Pilot studies and partnerships in 2024-2025 target vaccines and insulin; needle-free device markets projected CAGR ~7-9% through 2030, offering Daicel material revenue upside vs its FY2024 ¥314.6bn sales.
- Technology: micro-gas generators for transdermal delivery
- Market: needle-free devices CAGR ~7-9% to 2030
- Strategic: expands Daicel from automotive to healthcare
- Financial: complements FY2024 group sales ¥314.6bn, new revenue stream potential
AI/IoT and bio-refinery drives 12-18% yield gains, 20% less downtime, ¥40-60bn green capex
AI/IoT digitization raised yields 12-18% and cut unplanned downtime 20% (2024); predictive maintenance lowered energy intensity 15% FY2024. Bio-refinery pilot enzymatic yields climbed 45%→62% (2021→2024), targeting >30% fossil-feedstock cut by 2030 with ¥40-60bn sustainability capex through 2025-26. Battery binder/separator demand grows ~20% CAGR to 2030; FY2024 sales ¥314.6-¥300bn; needle-free devices CAGR ~7-9%.
| Metric | Value |
|---|---|
| Yield uplift (pilot) | 12-18% |
| Unplanned downtime | -20% |
| Energy intensity | -15% FY2024 |
| Enzymatic yield | 45%→62% (2021→2024) |
| Sustainability capex | ¥40-60bn (2025-26) |
| FY2024 sales | ¥314.6bn (group ~¥300bn) |
| EV battery market CAGR | ~20% to 2030 |
| Needle-free devices CAGR | 7-9% to 2030 |
Legal factors
Chemical Substance Regulations
Daicel must comply with a complex web of chemical regulations such as REACH in Europe and equivalent laws elsewhere; non-compliance risks fines-REACH penalties can exceed EUR 100,000 per infraction-and product recalls that hit revenue and reputation.
Stricter controls and potential PFAS bans force continuous reformulation; industry estimates show PFAS restrictions could affect >10% of specialty-chemical product lines.
Legal compliance is non-negotiable, and Daicel maintains a dedicated regulatory affairs team (~100 specialists globally in 2025) to manage evolving requirements across markets.
Intellectual Property Rights
Protecting proprietary chemical formulas, manufacturing processes, and pyrotechnic designs is critical for Daicel; the company held over 6,000 global patents as of 2024 to shield innovations and manufacturing know-how.
Daicel actively files patents worldwide to prevent copying-R&D spending reached ¥54.2 billion in FY2023, enabling continual patent filings and portfolio expansion.
Patent litigation is common in high-tech materials; Daicel has both pursued and defended infringement claims to protect market share and licensing revenue streams.
Robust IP management lets Daicel monetize R&D-patent licensing and protected products support margins and sustain technological leadership in specialty chemicals and safety systems.
Product Liability and Safety Law
As a supplier of airbag inflators, Daicel faces heavy product liability risk; recalls in the auto parts sector averaged $2.2bn annually in 2023-24, underlining exposure to costly litigation and reputational harm in the US and EU.
Daicel enforces ISO 9001/TS 16949-aligned quality controls and reported ¥18.4bn in quality-related costs and provisions in FY2024 to manage defects and legal claims.
The company carries comprehensive liability insurance and contingency reserves; continuous tracking of evolving US and EU safety regulations ensures products meet or exceed legal benchmarks and limits litigation risk.
Labor and Employment Legislation
Daicel must comply with evolving labor laws across Japan and other markets, notably regulations on working hours and equal pay; Japan's Work Style Reform Act (2019) limits overtime and promotes well-being, impacting staffing costs and productivity.
With Japan tightening DEI reporting-non-financial disclosures rising-Daicel faces mandatory reporting and potential penalties; compliance reduces litigation risk and supports workforce stability.
- Work Style Reform Act: caps overtime, affects labor costs
- DEI reporting growth: increased non-financial disclosure expectations
- Compliance prevents disputes, protects productivity and reputation
Environmental Disclosure Mandates
New mandates (e.g., Japan's 2022 Stewardship Code updates and anticipated SEC-like rules) require listed firms to disclose scope 1-3 emissions and climate-related financial risks; Daicel must report these metrics publicly.
Daicel legally discloses carbon emissions (scopes 1-2: reported 2024 combined ~240 ktCO2e), water withdrawal and waste volumes in filings; inaccuracies risk regulatory penalties and investor action.
Legal and sustainability teams coordinate to ensure disclosures meet evolving standards (TCFD, ISSB), integrating third-party assurance and aligning with FY2024 reporting timelines.
- Mandatory scope 1-3 disclosure, FY2024: ~240 ktCO2e scopes 1-2 reported
- Water and waste metrics included in annual report and CDP submission
- Third-party assurance and TCFD/ISSB alignment enforced by legal/sustainability
Daicel under regulatory, PFAS and liability pressure despite strong IP and R&D
Daicel faces strict chemical regulations (REACH fines >EUR100k/infraction), PFAS restrictions impacting >10% product lines, and mandatory scope 1-3 disclosures (scopes 1-2 ~240 ktCO2e in 2024); IP protection (6,000+ patents in 2024) and product liability (auto recalls avg $2.2bn/yr sector) drive heavy legal, insurance and compliance costs (R&D ¥54.2bn FY2023; quality provisions ¥18.4bn FY2024).
| Metric | Value |
|---|---|
| Global patents (2024) | 6,000+ |
| R&D spend (FY2023) | ¥54.2bn |
| Quality provisions (FY2024) | ¥18.4bn |
| Scopes 1-2 CO2e (2024) | ~240 ktCO2e |
| PFAS impact | >10% product lines |
Environmental factors
Carbon Neutrality Initiatives
Daicel targets carbon neutrality by 2050 with near-term 2030 goals to cut Scope 1-3 GHG emissions by 30% versus 2019, shifting manufacturing to renewables and improving process energy efficiency that reduced site energy use ~12% 2019-2024; the firm pilots carbon capture and utilization and estimates CAPEX of JPY 40-60 billion through 2030 to meet targets, critical for accessing ESG-linked finance and green bond markets.
Circular Economy and Recycling
Daicel has stepped up R&D into recyclable and biodegradable polymers-including cellulose acetate-to address the global plastic waste crisis, supporting industry targets to cut plastic leakage by 2030; cellulose acetate, derived from cellulose, reduces reliance on fossil feedstocks and aligns with circular-economy goals. The firm reports pilot closed-loop programs recovering and repurposing spent acetate in packaging and film, lowering virgin resin use and diverting waste from landfills. These moves also aim to capture growth in sustainable materials markets, estimated at over USD 150 billion by 2025, and reduce lifecycle emissions versus conventional plastics.
Water Resource Management
Daicel, operating water – intensive chemical processes, has invested in advanced wastewater treatment and on-site recycling, cutting freshwater intake by up to 28% at key plants (2024 internal reports).
Routine monitoring ensures discharge meets stringent standards; recent compliance rates exceeded 99% across major facilities in FY2024.
With UNEP projecting freshwater stress rising to affect 40% of global population by 2030, efficient water use is both an environmental imperative and a cost driver for Daicel's operations.
Biodiversity and Land Use
Daicel enforces sustainable-forestry sourcing for wood pulp used in cellulose, aligning with certifications to avoid deforestation; in 2024 over 70% of its pulp suppliers met recognized sustainability standards, reducing supply-chain biodiversity risks.
Manufacturing sites implement habitat-impact controls and restoration programs, cutting local disturbance and water-use intensity by roughly 15% from 2019-2024.
Promoting sustainable land use helps secure raw-material supply and mitigates regulatory and reputational risks tied to biodiversity loss.
- 70%+ pulp suppliers certified (2024)
- 15% reduction in site water-use intensity (2019-2024)
- Sustainable sourcing reduces deforestation and supply risk
Climate Risk Resilience
Daicel faces physical climate risks-typhoons and flooding-that threaten its manufacturing sites, with Japan recording a 20% rise in extreme rainfall events since 2000, increasing disruption risk to supply chains.
The company performs periodic environmental risk assessments across facilities and has invested in protective measures, contributing to its target of reducing climate-related operational losses by 30% by 2030.
Enhancing resilience to extreme weather protects business continuity, employee safety, and nearby communities, aligning with Daicel's sustainability commitments and capital expenditure planning for hardened infrastructure.
- Regular risk assessments identify vulnerable sites
- Investments aimed at 30% cut in climate-related losses by 2030
- Focus on staff/community safety and hardened infrastructure
Daicel: Carbon neutrality by 2050-30% GHG cut by 2030, JPY40-60bn green CAPEX
Daicel targets carbon neutrality by 2050 with a 2030 target to cut Scope 1-3 GHGs 30% from 2019, plans JPY 40-60bn CAPEX to 2030, cut site energy ~12% (2019-2024), advanced recycling of cellulose acetate and 70%+ certified pulp suppliers (2024), 28% freshwater intake reduction at key plants, and aims to cut climate-related losses 30% by 2030.
| Metric | Value |
|---|---|
| 2030 GHG cut target | 30% vs 2019 |
| 2050 goal | Carbon neutrality |
| CAPEX to 2030 | JPY 40-60bn |
| Energy use change | -12% (2019-2024) |
| Certified pulp suppliers | 70%+ |
| Freshwater intake reduction | 28% at key plants |
| Climate-loss reduction target | -30% by 2030 |
Frequently Asked Questions
The PESTEL delivers a company-specific, ready-made external analysis focused on Daicel's industries and product lines to save you time it provides the Pre-Written Company-Specific Analysis benefit and structured insights across Political, Economic, Social, Technological, Legal, and Environmental dimensions so you can move from raw data to strategic conclusions quickly and credibly.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.